Binghao Zhao (Wenbin Ma)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Newly Diagnosed

Top Venues

Molecular medicine (Cambridge, Mass.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Binghao Zhao, Jiaming Wu, Huanzhang Li, Yuekun Wang, Yaning Wang, Hao Xing, Yu Wang, Wenbin Ma
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma. Cell communication and signaling : CCS 21 (1) (2023)
Binghao Zhao, Jiaming Wu, Huanzhang Li, Wenbin Ma
Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Binghao Zhao, Yu Xia, Fengchun Yang, Yaning Wang, Yuekun Wang, Yadong Wang, Congxin Dai, Yu Wang, Binghao Zhao
Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor. Molecular medicine (Cambridge, Mass.) 28 (1) (2022)
Binghao Zhao, Huanzhang Li, Yu Xia, Yaning Wang, Yuekun Wang, Yixin Shi, Hao Xing, Tian Qu, Yu Wang, Wenbin Ma
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. Journal of hematology & oncology 15 (1) (2022)
Binghao Zhao, Wenbin Ma
Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better? Neuro-oncology 23 (9) (2021)
Binghao Zhao, Yuekun Wang, Yaning Wang, Wenlin Chen, Peng Hao Liu, Ziren Kong, Congxin Dai, Yu Wang, Binghao Zhao
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Journal of cellular physiology 236 (1) (2020)